offer
-
Medical Research
Groundbreaking Advancements in Ovarian Cancer Treatment: Keytruda and Lifyorli Offer New Hope for Platinum-Resistant Disease
In a significant stride for oncology, two distinct pharmaceutical agents, Keytruda (pembrolizumab) from Merck & Co. (known as MSD outside…
Read More » -
Mental Health
Unraveling the Subtle Neural Signatures of Schizophrenia: Emotion Recognition Deficits in Patients and Their Relatives Offer New Insights
Individuals diagnosed with schizophrenia frequently face significant challenges in recognizing emotions, a core deficit that profoundly impacts their social interactions…
Read More »